Real-World Data Show Zanubrutinib Delivers Strong Results in 410 Leukemia Patients
A nationwide cohort of 410 patients shows zanubrutinib delivers high progression-free survival in CLL/SLL, with dose reductions and switches between ...
A nationwide cohort of 410 patients shows zanubrutinib delivers high progression-free survival in CLL/SLL, with dose reductions and switches between ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine